P.V Ramprasad Reddy Biography & Net Worth

P.V Ramprasad Reddy Biography & Net Worth

P.V Ramprasad Reddy is the name of a renowned business tycoon from India. A dedicated and hardworking industrialist, Reddy is associated with the Aurobindo Pharma which he helped in establishing in the year 1986. He founded the pharmaceutical company along with his brother-in-law and his ownership in the business has multiplied in the last few years. His shares increased substantially after a ban on import was lifted by the United States FDA which had been enforced for the 2011 manufacturing lapses. Since then, his company’s shares have gone up tremendously and the business has also been expanding across continents including Asia and Europe where it is now regarded as one of the biggest generics makers and marketers in the business. Aurobindo also took over Actavis, a famous European medical business as well as the Irish drug company Natrol.

Reddy’s wealth has been increasing consistently over the last couple of years. He is regarded as one of the wealthiest businessmen of Indian origin, and his involvement in the flourishing pharmaceutical industry ensures that he continues to prosper as one of the biggest names in the business. Now, let’s continue the article below with full details of his career, meteoric rise to fame, personal life, and financial situation.

Early Life: Childhood, Education

Although his date of birth isn’t available in the media, we’re aware that the entrepreneur was born and brought up in India.
As far as we could find pertaining to his education, Reddy attended a University within his country of origin and later completed his post-graduate studies in commerce.

Professional Life: Business Career

Since 2012 Mr. P.V Ramprasad Reddy has been serving as the executive chairman of Aurobindo Pharma Inc, a pharma company he co-founded in the United States back in 1986. In addition, he has also rendered his services as the company’s non-executive chair, all in a bid to push the company to greater heights.
He is the current director of the APL Pharma Thai Co. Limited, the APL Holdings Incorporated, the Aurobindo Tongling, Aurobindo, and Bio Pharma Co. Ltd, all of which are subsidiaries to the holding Aurobindo Pharma Company Limited. It was in 1986 that he made the life-changing decision for himself by collaborating to establish Aurobindo Pharma which he has led as chairman and executive director.

Reddy and his wife of many years, Suneela Rani, reportedly control roughly 38 percent of the Aurobindo Pharma, according to data available on the Bombay Stock Exchange where the firm is currently trading. Excluding from the shares that stand as collateral for future loans and other events, the interest of the company, as at the present time, is valued to be worth more than $1 billion. Investors have been hinting and staking on the upward surge of the company’s shares after the United States health regulating agency FDA approved the generic version of Cymbalta antidepressants which the company is well-known to manufacture. With its recent acquisition of the Actavis Company, Aurobindo Pharma has found the platform it always needed to penetrate into several other markets. As we write this, the medical giant is hailed as one of the biggest players in the entire drug industry.

To break things down further, Reddy owns about 6.7 percent of the company’s shares while his wife owns 31.2 percent. He gave his spouse a share of 60 million that represented a 20.6 percent stake in 2012.

Aurobindo Pharma went public in 2005 despite having been trading since 1986 when it was founded. Over time, the brand has broadened to manufacture and market almost all known kinds of drugs, including drugs used for anti-diabetic, gastroenterological, antiretroviral, and cardiovascular treatments. Likewise, the company has also spread its tentacles to include the production and sales of medicines of a higher caliber. The company makes its annual revenue from the 125 countries where it carries out its operations.

Achievements: Awards & Honors

PV Ramprasad Reddy is a highly inspirational and influential figure in his country and elsewhere in the world. Several respectable bodies in the media have cited his works, and he has also been recognized and appreciated by some of these entities. For instance, The World Pharmaceutical Guide listed him among the 35 most influential people of the pharmaceutical industry in 2008, in recognition of his contributions to, and accomplishments in the industry.

Personal Life, Family, Wife, Children

Reddy and his wife of many years, Suneela Rani, are the parents of two adult children. The couple maintains their residence in Hyderabad, India, but primarily live in the United States where their major business venture is headquartered.

P.V. Ramprasad Reddy Net Worth: Income Sources, Salary, Shares

The Indian businessman and entrepreneur, P.V. Ramprasad Reddy, is said to manage a net worth of $2.3 billion, as estimated in several online publications in 2021 including Forbes magazine and Bloomberg Billionaires Index. His wealth is influenced by the generic company Aurobindo Pharma which he co-founded with his brother-in-law in 1986. The shares of the said company more than tripled in 2014 after the United States FDA lifted a ban on drug imports which was imposed three years earlier.

Reddy’s Aurobindo has since blown up in the pharmaceutical scene. Its sights have been set on becoming one of the biggest generic drugs manufacturers in the world, and this has been evidenced by its acquisition of various other brands, including Irish company Actavis and nutritional supplements’ maker Natrol, in a deal which was valued at more than $200 million.